Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review
K Mohamed, N Yazdanpanah, A Saghazadeh… - Bioorganic …, 2021 - Elsevier
Background Since the beginning of the novel coronavirus (SARS-CoV-2) disease outbreak,
there has been an increasing interest in finding a potential therapeutic agent for the disease …
there has been an increasing interest in finding a potential therapeutic agent for the disease …
Computational studies by molecular docking of some antiviral drugs with COVID-19 receptors are an approach to medication for COVID-19
The COVID-19 outbreak is a matter of concern worldwide due to unavailability of promising
treatment comprising medication or vaccination till date. The discovery of antiviral drug is of …
treatment comprising medication or vaccination till date. The discovery of antiviral drug is of …
A conceptual deep learning framework for COVID-19 drug discovery
The analytical and experimental methods used for the development of drugs have some
disadvantages in the aspect of the needed time for preparation of the desired …
disadvantages in the aspect of the needed time for preparation of the desired …
[HTML][HTML] Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics
With more than 5 million fatalities and close to 300 million reported cases, COVID-19 is the
first documented pandemic due to a coronavirus that continues to be a major health …
first documented pandemic due to a coronavirus that continues to be a major health …
COVID-19 treatment: Much research and testing, but far, few magic bullets against SARS-CoV-2 coronavirus
VV Kouznetsov - European Journal of Medicinal Chemistry, 2020 - Elsevier
The new virus of the of β-Coronaviruses genus, SARS-CoV-2, is the causative agent of
coronavirus disease-2019 (COVID-19) and is winning a proverbial chess match against all …
coronavirus disease-2019 (COVID-19) and is winning a proverbial chess match against all …
[HTML][HTML] Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
C Wu, Y Liu, Y Yang, P Zhang, W Zhong… - … Pharmaceutica Sinica B, 2020 - Elsevier
SARS-CoV-2 has caused tens of thousands of infections and more than one thousand
deaths. There are currently no registered therapies for treating coronavirus infections …
deaths. There are currently no registered therapies for treating coronavirus infections …
Emergence of new disease: how can artificial intelligence help?
Emergence of new disease remains a critical parameter in human health and society.
Advances in artificial intelligence (AI) allow for rapid processing and analysis of massive and …
Advances in artificial intelligence (AI) allow for rapid processing and analysis of massive and …
Genomics insights of SARS-CoV-2 (COVID-19) into target-based drug discovery
P Chellapandi, S Saranya - Medicinal Chemistry Research, 2020 - Springer
Abstract Coronavirus disease (COVID-19) pandemic is caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is a global health emergency and no …
syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is a global health emergency and no …
A revisit to the research updates of drugs, vaccines, and bioinformatics approaches in combating COVID-19 pandemic
A new strain of coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
responsible for the coronavirus disease 2019 (COVID-19) pandemic was first detected in the …
responsible for the coronavirus disease 2019 (COVID-19) pandemic was first detected in the …
Shape-based machine learning models for the potential novel COVID-19 protease inhibitors assisted by molecular dynamics simulation
A Nayarisseri, R Khandelwal… - Current topics in …, 2020 - ingentaconnect.com
Background: The vast geographical expansion of novel coronavirus and an increasing
number of COVID-19 affected cases have overwhelmed health and public health services …
number of COVID-19 affected cases have overwhelmed health and public health services …